Octreotide is a medication used in the management and treatment of acromegaly and thyrotrophinomas. It is in the somatostatin analog class of drugs. This activity describes the indications, action, and contraindications for octreotide as a valuable agent in the management of acromegaly and thyrotrophinomas, as well as carcinoid syndrome. This activity also highlights the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the management of patients with endocrinopathies and related conditions.

**Objectives:**
- Identify the most common adverse events associated with octreotide therapy.
- Review the contraindication of octreotide therapy.
- Explain the importance of monitoring for patients on octreotide therapy.
- Summarize the importance of improving care coordination among the interprofessional team to enhance care delivery for patients on octreotide therapy.